RxDoctor Payments Data

Francisco Oliva

Foot Surgery · Coral Gables, FLNPI 1568459857

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 36.7% of the total. Reporting peaked in 2019 at $3,379 and has fallen 75.3% since, to $835 in 2025.

$7,175in general payments, 2019–2025

Across 81 payments — averaging $88.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$3K
  • Amniox Medical, Inc.$856
  • Biotissue Holdings Inc.$520
  • Smith+Nephew$506
  • Stryker$372
  • Organogenesis Inc.$353
  • plus $2K from 23 others
$104,445in research payments, 2019–2025

Across 10 payments — averaging $10,444 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Royal Biologics, Inc.$104K

What the payments were for

  • Consulting fees$3505%
  • Speaking & faculty fees$841%
  • Travel & lodging$3,05043%
  • Food & beverage$3,52849%
  • Entertainment$1632%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,175 in reported general payments places this provider in the 85th percentile of 107 foot surgery providers in Florida.

See all foot surgery providers in Florida

Medicare billing

Part B allowed, 2024
$126,302
Medicare patients
456
Services billed
1,670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox101$2,358
CiclopiroxCiclopirox Olamine99$1,638
Ammonium Lactate66$1,481
Ketoconazole54$1,145
Diclofenac Sodium12$219
Ibuprofen24$117
Silver Sulfadiazine22$110
Cephalexin20$94
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$93
Tramadol Hcl12$28
Meloxicam13$26

Paid to pharmacies, not to this prescriber.

Other foot surgery in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →